Precision Biosciences Inc (DTIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -65,857 | -44,085 | -20,565 | 7,167 | 24,912 |
| Depreciation Amortization | 1,393 | 950 | 432 | 3,882 | 3,314 |
| Accounts receivable | 225 | 229 | 225 | 672 | 713 |
| Accounts payable and accrued liabilities | 313 | 93 | -106 | -2,096 | -2,168 |
| Other Working Capital | -2,495 | -4,380 | -1,759 | -55,989 | -65,257 |
| Other Operating Activity | 11,828 | 7,870 | 2,721 | -12,081 | -1,276 |
| Operating Cash Flow | $-54,593 | $-39,323 | $-19,052 | $-58,445 | $-39,762 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -44 | -61 | -64 | -190 | -93 |
| Purchase Sale Intangibles | -265 | -265 | -250 | -25 | -25 |
| Other Investing Activity | -265 | -265 | -250 | -25 | -25 |
| Investing Cash Flow | $-309 | $-326 | $-314 | $-215 | $-118 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 22,468 | 22,488 |
| Common Stock Issued | 17,646 | 15,987 | 10,687 | 50,487 | 44,547 |
| Other Financing Activity | 0 | 0 | 0 | -22,505 | -22,505 |
| Financing Cash Flow | $17,646 | $15,987 | $10,687 | $50,450 | $44,530 |
| Beginning Cash Position | 108,468 | 108,468 | 108,468 | 116,678 | 116,678 |
| End Cash Position | 71,212 | 84,806 | 99,789 | 108,468 | 121,328 |
| Net Cash Flow | $-37,256 | $-23,662 | $-8,679 | $-8,210 | $4,650 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,593 | -39,323 | -19,052 | -58,445 | -39,762 |
| Capital Expenditure | -66 | -66 | -64 | -250 | -153 |
| Free Cash Flow | -54,659 | -39,389 | -19,116 | -58,695 | -39,915 |